Medicines Management, Optimisation and Information

Guidance for efficient use of off-tariff medicines (Feb 2014)

Principles for sharing the benefits associated with more efficient use of medicines not reimbursed through national prices. NHS England’s medicines optimisation clinical reference group has published a document setting out how NHS England can work with providers incentivise more efficient use of high cost drugs excluded from the national tariff.

Medicines optimisation briefing for asthma (Feb 2014)

The Royal Pharmaceutical Society has published a briefing on medicines optimisation which focuses on asthma. The briefing encourages pharmacists to enquire about the patient’s experience, appropriateness of the medicine and the safety and effectiveness of the medication for the patient. It details steps to take and questions to ask to ensure the patient is getting the most out of their medicine. The document also contains case studies to show how medicines optimisation can benefit patients.

Medicines Optimisation Framework (Jan 2014)

The purpose of this TDA Medicines Optimisation Framework developed by the Trust Development Agency is to help NHS Trusts to review their approach to medicines optimisation and pharmaceutical srevices. The outcome will be used by the TDA to provide an assessment of the extent and quality of services provided by NHS Trusts.

Safe use of medications in care facilities (Nov 2013)

The National Care Forum has published resources to improve medicines management in care homes. The pack includes guides for employers and patients, and assessment tools and guidance on preventing medication errors.

Optimising medicines use in care pathways using pharmacy support and Medicines in Commissioning Toolkit Vs4.1 (Sept 2013)

Optimising medicines use in care pathways using pharmacy support and the Medicines in Commissioning Toolkit (link) are two key interlinked resources that have been revised and updated to support commissioners to help ensure care pathways which involve medicines deliver improved patient outcomes, are safe, use clinical and cost effective treatment options, offer patient choice and the best patient experience.

The resources emphasise the delivery of QIPP and the NHS Outcomes Framework, and, above all, demonstrate how to maximise patient outcomes through medicines optimisation. Both will also be useful to service providers, helping them to identify and address medicines-related issues in service specifications and comply with Care Quality Commission (CQC) Outcome 9 (Medicines Management).

In the current, rapidly changing, NHS environment these documents will provide a valuable starting point for local discussions between pharmacists and commissioners about the benefits and practicalities of commissioning medicines management support and appropriate pharmaceutical care for patients prescribed complex long and short term medication regimens.
Optimising medicines use in care pathways Vs1Sep12 (LD).pdf 

RPS has published a report titled Improving patient outcomes: The better use of multi-compartment compliance aids (July 2013)

Report includes guidance and recommendations for health and social care professionals. The report calls for a patient-centred approach to designing care that helps people to best use their medicines. The use of MCA has come to be regarded as a panacea for medicines use and is often integrated into practice and service policy without giving due consideration to the alternatives available. RPS believes that leadership and appropriate incentives are required to promote change that supports patient capability, independence and re-ablement.

Articles that previously appeared on this page have been moved into this section's archive and can be accessed by clicking here.